Page last updated: 2024-09-03

mk 0663 and Acute Rheumatic Fever

mk 0663 has been researched along with Acute Rheumatic Fever in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boice, JA; Curtis, SP; Frontera, N; Greenwald, M; Mandel, D; Mehta, A; Peloso, PM; Soto, O; Zhan, XJ	1

Trials

1 trial(s) available for mk 0663 and Acute Rheumatic Fever

Article	Year
Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis. Current medical research and opinion, 2011, Volume: 27, Issue:10 Topics: Aged; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Pain; Pyridines; Rheumatic Fever; Sulfones	2011

Article

Year

Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis.

Current medical research and opinion, 2011, Volume: 27, Issue:10

Topics: Aged; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Pain; Pyridines; Rheumatic Fever; Sulfones

2011